Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in J Immunother Retrieve available abstracts of 46 articles: HTML format Text format

Single Articles

November 2011
1. WEBER JS , Hamid O, Chasalow SD, Wu DY, et al
   Ipilimumab Increases Activated T Cells and Enhances Humoral Immunity in Patients With Advanced Melanoma.
   J Immunother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. THOMPSON JA , Hamid O, Minor D, Amin A, et al
   Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma: Retrospective Analysis of Efficacy and Safety Data from a Phase II Trial.
   J Immunother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. HARRIS RC , Chianese-Bullock KA, Petroni GR, Schaefer JT, et al
   The Vaccine-site Microenvironment Induced by Injection of Incomplete Freund's Adjuvant, With or Without Melanoma Peptides.
   J Immunother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. JOSEPH RW , Sullivan RJ, Harrell R, Stemke-Hale K, et al
   Correlation of NRAS Mutations With Clinical Response to High-dose IL-2 in Patients With Advanced Melanoma.
   J Immunother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. ALEXANDRESCU DT , Ichim TE, Riordan NH, Marincola FM, et al
   IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?
   J Immunother. 2011;34:607-609.
   PubMed     Text format     Related articles   
   
   
   
   September 2011
6. TORISU-ITAKURA H , Schoellhammer HF, Sim MS, Irie RF, et al
   Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T Cells.
   J Immunother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. FARKAS A , Kemeny L
   Interferon-conditioned Dendritic Cells for Melanoma Immunotherapy.
   J Immunother. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. ALEXANDRESCU DT , Ichim TE, Riordan NH, Marincola FM, et al
   IFN-Conditioned Dendritic Cells for the Therapy of Melanoma: What is Missing?
   J Immunother. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. MAITITUOHETI M , Li Y, Wang W, Wang W, et al
   Adeno-Associated Virus-Mediated Local Delivery of LIGHT Suppresses Tumorigenesis in a Murine Cervical Cancer Model.
   J Immunother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WEBER JS , Vogelzang NJ, Ernstoff MS, Goodman OB, et al
    A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors.
    J Immunother. 2011;34:556-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MENG Z , Wang Y, Zhang G, Ke Y, et al
    Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations.
    J Immunother. 2011;34:525-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
12. GRIGNOL VP , Olencki T, Relekar K, Taylor C, et al
    A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma.
    J Immunother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WILGENHOF S , Van Nuffel AM, Corthals J, Heirman C, et al
    Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma.
    J Immunother. 2011;34:448-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SAMLOWSKI WE , Kondapaneni M, Tharkar S, McGregor JR, et al
    Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
    J Immunother. 2011;34:419-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
15. ZIEFLE S , Egberts F, Heinze S, Volkenandt M, et al
    Health-related Quality of Life Before and During Adjuvant Interferon-alpha Treatment for Patients With Malignant Melanoma (DeCOG-Trial).
    J Immunother. 2011;34:403-408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KERKAR SP , Sanchez-Perez L, Yang S, Borman ZA, et al
    Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.
    J Immunother. 2011;34:343-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
17. HERNANDEZ-CHACON JA , Li Y, Wu RC, Bernatchez C, et al
    Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function.
    J Immunother. 2011;34:236-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. WONG JL , Mailliard RB, Moschos SJ, Edington H, et al
    Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells.
    J Immunother. 2011;34:270-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. LIU P , Zhang C, Chen J, Zhang R, et al
    Combinational Therapy of Interferon-alpha and Chemotherapy Normalizes Tumor Vasculature by Regulating Pericytes Including the Novel Marker RGS5 in Melanoma.
    J Immunother. 2011;34:320-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
20. YOSHIMOTO K , Kishida T, Nakano H, Matsui M, et al
    Interleukin-28B acts synergistically with cisplatin to suppress the growth of head and neck squamous cell carcinoma.
    J Immunother. 2011;34:139-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. ITZHAKI O , Hovav E, Ziporen Y, Levy D, et al
    Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy.
    J Immunother. 2011;34:212-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
22. MULLER JM , Feige K, Wunderlin P, Hodl A, et al
    Double-blind Placebo-controlled Study With Interleukin-18 and Interleukin-12-encoding Plasmid DNA Shows Antitumor Effect in Metastatic Melanoma in Gray Horses.
    J Immunother. 2011;34:58-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. JOHNSON EE , Buhtoiarov IN, Baldeshwiler MJ, Felder MA, et al
    Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice.
    J Immunother. 2011;34:76-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
24. INOZUME T , Hanada KI, Wang QJ, Ahmadzadeh M, et al
    Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. DENGEL LT , Norrod AG, Gregory BL, Clancy-Thompson E, et al
    Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LEE SH , Baig M, Rusciano V, Dutcher JP, et al
    Novel Management of Pruritus in Patients Treated With IL-2 for Metastatic Renal Cell Carcinoma and Malignant Melanoma.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
27. VOGEL TU , Visan L, Ljutic B, Gajewska B, et al
    Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ROBERTS DJ , Franklin NA, Kingeter LM, Yagita H, et al
    Control of Established Melanoma by CD27 Stimulation Is Associated With Enhanced Effector Function and Persistence, and Reduced PD-1 Expression of Tumor Infiltrating CD8+ T Cells.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KALBASI A , Fonsatti E, Natali PG, Altomonte M, et al
    CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. FINKELSTEIN SE , Carey T, Fricke I, Yu D, et al
    Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HEINZERLING LM , Anliker MD, Muller J, Schlaeppi M, et al
    Sarcoidosis Induced by Interferon-alpha in Melanoma Patients: Incidence, Clinical Manifestations, and Management Strategies.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. GOFF SL , Smith FO, Klapper JA, Sherry R, et al
    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SPEISER DE , Schwarz K, Baumgaertner P, Manolova V, et al
    Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
34. HANGALAPURA BN , Oosterhoff D, Aggarwal S, Wijnands PG, et al
    Selective Transduction of Dendritic Cells in Human Lymph Nodes and Superior Induction of High-avidity Melanoma-reactive Cytotoxic T Cells by a CD40-targeted Adenovirus.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LAURENT J , Speiser DE, Appay V, Touvrey C, et al
    Impact of 3 Different Short-term Chemotherapy Regimens on Lymphocyte-depletion and Reconstitution in Melanoma Patients.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. YANG S , Dudley ME, Rosenberg SA, Morgan RA, et al
    A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors.
    J Immunother. 2010;33:648-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
37. ALEXANDRESCU DT , Ichim TE, Riordan NH, Marincola FM, et al
    Immunotherapy for Melanoma: Current Status and Perspectives.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ROSENBERG SA , Yang JC, Kammula US, Hughes MS, et al
    Different Adjuvanticity of Incomplete Freund's Adjuvant Derived From Beef or Vegetable Components in Melanoma Patients Immunized With a Peptide Vaccine.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SLINGLUFF CL , Petroni GR, Smolkin ME, Chianese-Bullock KA, et al
    Immunogenicity for CD8+ and CD4+ T Cells of 2 Formulations of an Incomplete Freund's Adjuvant for Multipeptide Melanoma Vaccines.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ELLYARD JI , Quah BJ, Simson L, Parish CR, et al
    Alternatively activated macrophage possess antitumor cytotoxicity that is induced by IL-4 and mediated by arginase-1.
    J Immunother. 2010;33:443-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
41. ZHU X , Cai J, Huang J, Jiang X, et al
    The Treatment and Prevention of Mouse Melanoma With an Oral DNA Vaccine Carried by Attenuated Salmonella Typhimurium.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. FERNANDES E , Soans E, Xu J, Kieliszewski M, et al
    Novel Fusion Proteins of Interferon alpha2b Cause Growth Inhibition and Induce JAK-STAT Signaling in Melanoma.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. PRIETO PA , Durflinger KH, Wunderlich JR, Rosenberg SA, et al
    Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy.
    J Immunother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. LIU S , Etto T, Rodriguez-Cruz T, Li Y, et al
    TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
    J Immunother. 2010;33:371-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
45. MOSCHOS SJ , Sander CA, Wang W, Reppert SL, et al
    Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.
    J Immunother. 2010;33:316-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. RISBERG K , Fodstad O, Andersson Y
    Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
    J Immunother. 2010;33:272-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: